Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2001 Apr;10(2):81–88. doi: 10.1080/09629350120054554

Release of tumor necrosis factor-alpha and prostanoids in whole blood cultures after in vivo exposure to low-dose aspirin.

I Beckmann 1, S Ben-Efraim 1, M Vervoort 1, H C Wallenburg 1
PMCID: PMC1781693  PMID: 11405554

Abstract

BACKGROUND: The preventive effect of low-dose aspirin in cardiovascular disease is generally attributed to its antiplatelet action caused by differential inhibition of platelet cyclooxygenase-1. However, there is evidence that aspirin also affects release of inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha). It is not known whether this is caused by direct action on the cytokine pathway or indirectly through cyclooxygenase inhibition and altered prostanoid synthesis, or both. METHODS: We assessed the capacity of lipopolysaccharide-activated leukocytes in whole blood cultures of eight healthy subjects following a single oral dose of 80 mg aspirin to release TNF-alpha, prostanoid E2 (PGE2) and prostanoid I2 (PGI2), and thromboxane A2 (TXA2). TNF-alpha and prostanoids were determined by enzyme-linked immunoassays. RESULTS: In seven subjects, TNF-alpha release in blood cultures decreased 24h after intake of aspirin. The effect of aspirin on prostanoid release was assessed in three individuals: PGE2 increased in all subjects, PGI2 increased in two and remained unchanged in one, and TXA2 was reduced in two and unchanged in one individual The presence of DFU, a specific inhibitor of cyclooxygenase 2, did not affect the reduction of TNF-alpha release by aspirin, but abolished prostanoid production in all three individuals. Conclusion: The capacity of activated leukocytes to release TNF-alpha is reduced by ingestion of low-dose aspirin, independent of changes in prostanoid biosynthesis.

Full Text

The Full Text of this article is available as a PDF (223.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. N., Herzyk D. J., Allen E. D., Wewers M. D. Human whole blood interleukin-1-beta production: kinetics, cell source, and comparison with TNF-alpha. J Lab Clin Med. 1992 May;119(5):538–546. [PubMed] [Google Scholar]
  2. Barth W., Jr Low-dose aspirin for preeclampsia--the unresolved question. N Engl J Med. 1998 Mar 12;338(11):756–757. doi: 10.1056/NEJM199803123381109. [DOI] [PubMed] [Google Scholar]
  3. Beckmann I., Meisel-Mikołajczyk F., Lotgering F. K., Wallenburg H. C. Tumor necrosis factor-alpha in response to endotoxin administration in the pregnant guinea pig. Am J Obstet Gynecol. 1996 Jul;175(1):218–221. doi: 10.1016/s0002-9378(96)70278-8. [DOI] [PubMed] [Google Scholar]
  4. Benedek I. H., Joshi A. S., Pieniaszek H. J., King S. Y., Kornhauser D. M. Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers. J Clin Pharmacol. 1995 Dec;35(12):1181–1186. doi: 10.1002/j.1552-4604.1995.tb04044.x. [DOI] [PubMed] [Google Scholar]
  5. Caughey G. E., Pouliot M., Cleland L. G., James M. J. Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes. J Immunol. 1997 Jan 1;158(1):351–358. [PubMed] [Google Scholar]
  6. Conrad K. P., Benyo D. F. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997 Mar;37(3):240–249. doi: 10.1111/j.1600-0897.1997.tb00222.x. [DOI] [PubMed] [Google Scholar]
  7. Eisenhut T., Sinha B., Gröttrup-Wolfers E., Semmler J., Siess W., Endres S. Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells. Immunopharmacology. 1993 Nov-Dec;26(3):259–264. doi: 10.1016/0162-3109(93)90042-o. [DOI] [PubMed] [Google Scholar]
  8. Endres S., Cannon J. G., Ghorbani R., Dempsey R. A., Sisson S. D., Lonnemann G., Van der Meer J. W., Wolff S. M., Dinarello C. A. In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol. 1989 Dec;19(12):2327–2333. doi: 10.1002/eji.1830191222. [DOI] [PubMed] [Google Scholar]
  9. Endres S., Whitaker R. E., Ghorbani R., Meydani S. N., Dinarello C. A. Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1 beta and of tumour necrosis factor-alpha ex vivo. Immunology. 1996 Feb;87(2):264–270. doi: 10.1046/j.1365-2567.1996.472535.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Entzian P., Linnemann K., Schlaak M., Zabel P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med. 1996 Mar;153(3):1080–1086. doi: 10.1164/ajrccm.153.3.8630548. [DOI] [PubMed] [Google Scholar]
  11. Ferrante J. V., Huang Z. H., Nandoskar M., Hii C. S., Robinson B. S., Rathjen D. A., Poulos A., Morris C. P., Ferrante A. Altered responses of human macrophages to lipopolysaccharide by hydroperoxy eicosatetraenoic acid, hydroxy eicosatetraenoic acid, and arachidonic acid. Inhibition of tumor necrosis factor production. J Clin Invest. 1997 Mar 15;99(6):1445–1452. doi: 10.1172/JCI119303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hartwig-Otto H. Pharmacokinetic considerations of common analgesics and antipyretics. Am J Med. 1983 Nov 14;75(5A):30–37. doi: 10.1016/0002-9343(83)90230-9. [DOI] [PubMed] [Google Scholar]
  13. Hennekens C. H. Aspirin in the treatment and prevention of cardiovascular disease. Annu Rev Public Health. 1997;18:37–49. doi: 10.1146/annurev.publhealth.18.1.37. [DOI] [PubMed] [Google Scholar]
  14. Heyborne K. D., Witkin S. S., McGregor J. A. Tumor necrosis factor-alpha in midtrimester amniotic fluid is associated with impaired intrauterine fetal growth. Am J Obstet Gynecol. 1992 Oct;167(4 Pt 1):920–925. doi: 10.1016/s0002-9378(12)80012-3. [DOI] [PubMed] [Google Scholar]
  15. Lecomte M., Laneuville O., Ji C., DeWitt D. L., Smith W. L. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem. 1994 May 6;269(18):13207–13215. [PubMed] [Google Scholar]
  16. Lee J. I., Burckart G. J. Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol. 1998 Nov;38(11):981–993. doi: 10.1177/009127009803801101. [DOI] [PubMed] [Google Scholar]
  17. Leitich H., Egarter C., Husslein P., Kaider A., Schemper M. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol. 1997 Apr;104(4):450–459. doi: 10.1111/j.1471-0528.1997.tb11497.x. [DOI] [PubMed] [Google Scholar]
  18. Meade E. A., Smith W. L., DeWitt D. L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 1993 Mar 25;268(9):6610–6614. [PubMed] [Google Scholar]
  19. Meldrum D. R. Tumor necrosis factor in the heart. Am J Physiol. 1998 Mar;274(3 Pt 2):R577–R595. doi: 10.1152/ajpregu.1998.274.3.R577. [DOI] [PubMed] [Google Scholar]
  20. Osnes L. T., Foss K. B., Joø G. B., Okkenhaug C., Westvik A. B., Ovstebø R., Kierulf P. Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-alpha) in human monocytes. Thromb Haemost. 1996 Dec;76(6):970–976. [PubMed] [Google Scholar]
  21. Osnes L. T., Haug K. B., Joø G. B., Westvik A. B., Ovstebø R., Kierulf P. Aspirin potentiates LPS-induced fibrin formation (FPA) and TNF-alpha-synthesis in whole blood. Thromb Haemost. 2000 Jun;83(6):868–873. [PubMed] [Google Scholar]
  22. Osterud B., Olsen J. O., Wilsgård L. Increased lipopolysaccharide-induced tissue factor activity and tumour necrosis factor production in monocytes after intake of aspirin: possible role of prostaglandin E2. Blood Coagul Fibrinolysis. 1992 Jun;3(3):309–313. doi: 10.1097/00001721-199206000-00011. [DOI] [PubMed] [Google Scholar]
  23. Renz H., Gong J. H., Schmidt A., Nain M., Gemsa D. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol. 1988 Oct 1;141(7):2388–2393. [PubMed] [Google Scholar]
  24. Riendeau D., Percival M. D., Boyce S., Brideau C., Charleson S., Cromlish W., Ethier D., Evans J., Falgueyret J. P., Ford-Hutchinson A. W. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol. 1997 May;121(1):105–117. doi: 10.1038/sj.bjp.0701076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rowlinson S. W., Crews B. C., Goodwin D. C., Schneider C., Gierse J. K., Marnett L. J. Spatial requirements for 15-(R)-hydroxy-5Z,8Z,11Z, 13E-eicosatetraenoic acid synthesis within the cyclooxygenase active site of murine COX-2. Why acetylated COX-1 does not synthesize 15-(R)-hete. J Biol Chem. 2000 Mar 3;275(9):6586–6591. doi: 10.1074/jbc.275.9.6586. [DOI] [PubMed] [Google Scholar]
  26. Rymark P., Berntorp E., Nordsjö P., Liedholm H., Melander A., Gennser G. Low-dose aspirin to pregnant women: single dose pharmacokinetics and influence of short term treatment on bleeding time. J Perinat Med. 1994;22(3):205–211. doi: 10.1515/jpme.1994.22.3.205. [DOI] [PubMed] [Google Scholar]
  27. Shackelford R. E., Alford P. B., Xue Y., Thai S. F., Adams D. O., Pizzo S. Aspirin inhibits tumor necrosis factoralpha gene expression in murine tissue macrophages. Mol Pharmacol. 1997 Sep;52(3):421–429. doi: 10.1124/mol.52.3.421. [DOI] [PubMed] [Google Scholar]
  28. Wallenburg H. C. Prevention of pre-eclampsia: status and perspectives 2000. Eur J Obstet Gynecol Reprod Biol. 2001 Jan;94(1):13–22. doi: 10.1016/s0301-2115(00)00303-1. [DOI] [PubMed] [Google Scholar]
  29. Westendorp R. G., Langermans J. A., Huizinga T. W., Elouali A. H., Verweij C. L., Boomsma D. I., Vandenbroucke J. P., Vandenbrouke J. P. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 1997 Jan 18;349(9046):170–173. doi: 10.1016/s0140-6736(96)06413-6. [DOI] [PubMed] [Google Scholar]
  30. Yin M. J., Yamamoto Y., Gaynor R. B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature. 1998 Nov 5;396(6706):77–80. doi: 10.1038/23948. [DOI] [PubMed] [Google Scholar]
  31. de Gaetano G., Cerletti C. Aspirin, platelets and prevention of vascular disease. J Lipid Mediat. 1989 Sep-Oct;1(5):289–296. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES